TD Private Client Wealth’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-8
Closed -$474 1198
2021
Q3
$474 Buy
+8
New +$474 ﹤0.01% 1175